AMEDISYS INC Quarterly Goodwill in USD from Q1 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Amedisys Inc quarterly Goodwill history and growth rate from Q1 2010 to Q4 2024.
  • Amedisys Inc Goodwill for the quarter ending December 31, 2024 was $1.21B, a 2.47% decline year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $1.21B -$30.8M -2.47% Dec 31, 2024 10-K 2025-02-27
Q3 2024 $1.24B $0 0% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $1.24B $0 0% Jun 30, 2024 10-Q 2024-07-25
Q1 2024 $1.24B $0 0% Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $1.24B -$42.7M -3.32% Dec 31, 2023 10-K 2025-02-27
Q3 2023 $1.24B -$40.8M -3.17% Sep 30, 2023 10-Q 2023-10-25
Q2 2023 $1.24B -$45M -3.49% Jun 30, 2023 10-Q 2023-07-27
Q1 2023 $1.24B +$40M +3.32% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $1.29B +$91.3M +7.63% Dec 31, 2022 10-K 2025-02-27
Q3 2022 $1.29B +$97.4M +8.2% Sep 30, 2022 10-Q 2022-10-27
Q2 2022 $1.29B +$353M +37.7% Jun 30, 2022 10-Q 2022-07-28
Q1 2022 $1.2B +$271M +29.1% Mar 31, 2022 10-Q 2022-04-28
Q4 2021 $1.2B +$263M +28.2% Dec 31, 2021 10-K 2024-02-22
Q3 2021 $1.19B +$257M +27.5% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $937M -$316K -0.03% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $933M +$212M +29.4% Mar 31, 2021 10-Q 2021-04-29
Q4 2020 $933M +$274M +41.6% Dec 31, 2020 10-K 2023-02-16
Q3 2020 $931M +$271M +41% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 $937M +$272M +41% Jun 30, 2020 10-Q 2020-07-29
Q1 2020 $721M +$71.5M +11% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $659M +$329M +99.8% Dec 31, 2019 10-K 2022-02-24
Q3 2019 $660M +$336M +104% Sep 30, 2019 10-Q 2019-10-30
Q2 2019 $665M +$341M +105% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $650M +$327M +102% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $330M +$9.6M +3% Dec 31, 2018 10-K 2021-02-25
Q3 2018 $324M +$10.5M +3.34% Sep 30, 2018 10-Q 2018-10-30
Q2 2018 $324M +$10.5M +3.34% Jun 30, 2018 10-Q 2018-08-01
Q1 2018 $322M +$29.4M +10% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $320M +$31M +10.7% Dec 31, 2017 10-K 2020-02-19
Q3 2017 $314M +$29.1M +10.2% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $314M +$33.3M +11.9% Jun 30, 2017 10-Q 2017-07-27
Q1 2017 $293M +$7.67M +2.69% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 $289M +$27.2M +10.4% Dec 31, 2016 10-K 2019-02-28
Q3 2016 $285M +$73.4M +34.8% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 $280M +$74.8M +36.4% Jun 30, 2016 10-Q 2016-08-03
Q1 2016 $285M +$79.5M +38.7% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 $262M +$56.1M +27.3% Dec 31, 2015 10-K 2019-02-28
Q3 2015 $211M +$5.52M +2.69% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 $206M $0 0% Jun 30, 2015 10-Q 2015-07-29
Q1 2015 $206M -$3.34M -1.6% Mar 31, 2015 10-Q 2015-04-29
Q4 2014 $206M -$3.3M -1.58% Dec 31, 2014 10-K 2018-02-28
Q3 2014 $206M -$2.54M -1.22% Sep 30, 2014 10-Q 2014-10-29
Q2 2014 $206M -$3.67M -1.76% Jun 30, 2014 10-Q 2014-07-30
Q1 2014 $209M -$1.07M -0.51% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 $209M -$700K -0.33% Dec 31, 2013 10-K 2017-03-01
Q3 2013 $208M -$159M -43.4% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $209M -$134M -39.1% Jun 30, 2013 10-Q 2013-07-31
Q1 2013 $210M -$125M -37.3% Mar 31, 2013 10-Q 2013-04-30
Q4 2012 $210M -$125M -37.4% Dec 31, 2012 10-K 2016-03-10
Q3 2012 $367M +$31.7M +9.44% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 $343M -$558M -61.9% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 $335M -$457M -57.7% Mar 31, 2012 10-Q 2012-05-09
Q4 2011 $335M -$457M -57.7% Dec 31, 2011 10-K 2015-03-04
Q3 2011 $336M -$455M -57.5% Sep 30, 2011 10-Q 2011-11-01
Q2 2011 $902M +$111M +14.1% Jun 30, 2011 10-Q 2011-08-02
Q1 2011 $791M +$2.36M +0.3% Mar 31, 2011 10-Q 2011-04-26
Q4 2010 $791M Dec 31, 2010 10-K 2014-03-12
Q3 2010 $790M Sep 30, 2010 10-Q 2010-10-26
Q2 2010 $790M Jun 30, 2010 10-Q 2010-08-09
Q1 2010 $789M Mar 31, 2010 10-Q 2010-04-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.